Skip to main content

Table 1 Frequency of the CHEK2 R95* germline mutation in the Norwegian population

From: Prevalence of the CHEK2 R95* germline mutation

Individuals/patients

R95*-carriersan

Wild-type n

Total

MAF

Non-cancer individuals

4

3744

3748

5.3 × 10−4

Cancer patients

8

7073

7081

5.6 × 10−4

 Breast cancer

4

1713

1717

1.2 × 10−3

 Prostate cancer

4

2497

2501

8.0 × 10−4

 Lung cancer

0

1331

1331

0

 Colorectal cancer

0

1532

1532

0

Total

12

10,817

10,829

5.5 × 10−4

  1. aAll R95* carriers were heterozygous